Cohance Lifesciences Limited (BOM:543064)
462.00
+2.85 (0.62%)
At close: Nov 20, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 176.87 billion as of November 20, 2026. Its market cap has decreased by 20.59% in one year.
Market Cap
176.87B
Enterprise Value
179.18B
Revenue
20.63B
Global Rank
n/a
Country Rank
n/a
PE Ratio
375.81
ChartMarket Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 176.87B, an increase of 524,673.02%. That is a compound annual growth rate of 258.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 176.87B | -12.54% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 350.43B |
| Piramal Pharma | 314.77B |
| Alembic Pharmaceuticals | 204.71B |
| Eris Lifesciences | 183.48B |
| Alivus Life Sciences | 176.54B |
| Cohance Lifesciences | 175.04B |
| NATCO Pharma | 159.89B |
| Sudeep Pharma | 135.54B |